FDA Inspection 1049269 — King Pharmaceuticals LLC

King Pharmaceuticals LLC — FEI 1876582

The FDA completed an inspection of King Pharmaceuticals LLC on March 14, 2018 in Rochester, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rochester, MI (United States)